Eisenstadt Richard I
Insider CIK 1515806 · TZYM VP, Finance & CFO · ALT Chief Financial Officer · AYTU Chief Financial Officer · NEOS Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALT Altimmune, Inc. | A Award | 2024-01-31 | 2024-02-01 | 4,621 | $2.69 | $12.4K | 45,012 | SEC↗ |
| ALT Altimmune, Inc. | M Exercise deriv | 2024-01-30 | 2024-02-01 | 9,275 | — | $0 | 27,825 | SEC↗ |
| ALT Altimmune, Inc. | M Exercise | 2024-01-30 | 2024-02-01 | 9,275 | — | $0 | 42,566 | SEC↗ |
| ALT Altimmune, Inc. | F Tax w/h | 2024-01-30 | 2024-02-01 | 2,175 | $9.80 | $21.3K | 40,391 | SEC↗ |
| ALT Altimmune, Inc. | A Award deriv | 2024-01-25 | 2024-01-29 | 163,200 | — | $0 | 163,200 | SEC↗ |
| ALT Altimmune, Inc. | A Award deriv | 2024-01-25 | 2024-01-29 | 58,400 | — | $0 | 58,400 | SEC↗ |
| ALT Altimmune, Inc. | M Exercise deriv | 2023-12-29 | 2024-01-02 | 12,500 | — | $0 | 25,000 | SEC↗ |
| ALT Altimmune, Inc. | M Exercise | 2023-12-29 | 2024-01-02 | 12,500 | — | $0 | 36,335 | SEC↗ |
| ALT Altimmune, Inc. | F Tax w/h | 2023-12-29 | 2024-01-02 | 3,044 | $11.25 | $34.2K | 33,291 | SEC↗ |
| ALT Altimmune, Inc. | A Award | 2023-07-31 | 2023-08-02 | 1,825 | $2.81 | $5.1K | 23,835 | SEC↗ |
| ALT Altimmune, Inc. | P Buy | 2023-03-24 | 2023-03-24 | 10,000 | $4.31 | $43.1K | 22,010 | SEC↗ |
| ALT Altimmune, Inc. | A Award | 2023-01-31 | 2023-02-02 | 1,172 | $10.21 | $12.0K | 12,010 | SEC↗ |
| ALT Altimmune, Inc. | A Award deriv | 2023-01-30 | 2023-02-01 | 105,000 | — | $0 | 105,000 | SEC↗ |
| ALT Altimmune, Inc. | A Award deriv | 2023-01-30 | 2023-02-01 | 37,100 | — | $0 | 37,100 | SEC↗ |
| ALT Altimmune, Inc. | M Exercise deriv | 2022-12-31 | 2023-01-03 | 12,500 | — | $0 | 37,500 | SEC↗ |
| ALT Altimmune, Inc. | F Tax w/h | 2022-12-31 | 2023-01-03 | 3,028 | $16.45 | $49.8K | 10,838 | SEC↗ |
| ALT Altimmune, Inc. | M Exercise | 2022-12-31 | 2023-01-03 | 12,500 | — | $0 | 13,866 | SEC↗ |
| ALT Altimmune, Inc. | A Award | 2022-07-31 | 2022-08-03 | 1,366 | $6.86 | $9.4K | 1,366 | SEC↗ |
| ALT Altimmune, Inc. | A Award deriv | 2021-12-31 | 2022-01-04 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ALT Altimmune, Inc. | A Award deriv | 2021-12-31 | 2022-01-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| AYTU AYTU BIOPHARMA, INC | A Award | 2021-03-31 | 2021-04-05 | 55,000 | — | $0 | 68,734 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | D To issuer deriv | 2021-03-19 | 2021-03-19 | 12,500 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | D To issuer deriv | 2021-03-19 | 2021-03-19 | 86,167 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | D To issuer deriv | 2021-03-19 | 2021-03-19 | 60,230 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | D To issuer deriv | 2021-03-19 | 2021-03-19 | 50,000 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | D To issuer deriv | 2021-03-19 | 2021-03-19 | 45,000 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | D To issuer deriv | 2021-03-19 | 2021-03-19 | 56,250 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | D To issuer deriv | 2021-03-19 | 2021-03-19 | 230,276 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | D To issuer deriv | 2021-03-19 | 2021-03-19 | 115,000 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | D To issuer | 2021-03-19 | 2021-03-19 | 126,245 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | F Tax w/h | 2021-03-02 | 2021-03-16 | 14,825 | $0.84 | $12.5K | 126,245 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | F Tax w/h | 2021-03-01 | 2021-03-16 | 1,390 | $0.88 | $1.2K | 141,070 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 115,000 | — | $0 | 115,000 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | A Award | 2020-03-02 | 2020-03-04 | 100,000 | — | $0 | 0 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | A Award deriv | 2019-03-01 | 2019-03-04 | 230,276 | — | $0 | 230,276 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | P Buy | 2018-12-12 | 2018-12-13 | 5,000 | $2.16 | $10.8K | 42,460 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | A Award deriv | 2018-03-01 | 2018-03-05 | 56,250 | — | $0 | 56,250 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | A Award | 2018-03-01 | 2018-03-05 | 18,750 | — | $0 | 37,460 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | A Award deriv | 2017-05-01 | 2017-05-02 | 45,000 | — | $0 | 45,000 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | A Award | 2017-05-01 | 2017-05-02 | 15,000 | — | $0 | 18,710 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | P Buy | 2016-08-25 | 2016-08-25 | 3,710 | $6.82 | $25.3K | 3,710 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | A Award deriv | 2016-04-01 | 2016-04-01 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NEOS Neos Therapeutics, Inc. | A Award deriv | 2015-09-01 | 2015-09-03 | 60,230 | — | $0 | 60,230 | SEC↗ |
| TZYM TRANZYME INC | A Award deriv | 2012-08-07 | 2012-08-09 | 40,000 | — | $0 | 40,000 | SEC↗ |